MENU

Published on 7/08/2020 6:58:50 PM | Source: Angel Broking Ltd

Quote on 1QFY21 results of Alkem Lab by Yash Gupta, Angel Broking

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel  https://t.me/InvestmentGuruIndia 

Download Telegram App before Joining the Channel

Below is the Quote on 1QFY21 results of Alkem Lab by Yash Gupta, Equity Research Associate, Angel Broking Ltd
“Alkem Laboratories reported a good set of numbers despite lockdown in Q1FY21. consolidated revenue from operations for Q1FY21 stood at ₹2,003.5 crores up by 8.3% YoY from ₹1,849.5 crores in Q1FY20, driven by strong growth in the US business which is up by 38.3%, from ₹481.7 Crore in Q1FY20 to ₹666.4 Crore in Q1FY21. Revenue from India Business down by 5.5%, from ₹1,222 Crore in Q1FY20 to ₹1155.0 Crore in Q1FY21. Gross margins stood at 63.4% in Q1FY21 up by 190 bps from 61.5% in Q1FY20. EBITDA for the quarter is up by 101.6% YoY to ₹533.2 Crores as compared to ₹264.5 Crores in Q1FY20 due to lower cost of materials and other expenses. Profit after tax for the quarter stood at ₹423.1 Crore up by 127% as compared to ₹187.2 Crore in Q1FY20.While the company posted above expected set of numbers for the quarter we believe that the margins expansion may not be sustainable in the future.”

 

Above views are of the author and not of the website kindly read disclaimer